Communiqués Exagen Inc.

Actions

XGN

US30068X1037

Installations et services en soins de santé

Marché Fermé - Nasdaq 22:00:00 14/09/2026			Varia. 5j.	Varia. 1 janv.
7,350 ^USD	+4,55%		-3,03%	+20,89%

05/08	Exagen Inc. : B. Riley favorable sur le dossier	ZM
04/08	Transcript : Exagen Inc., Q2 2026 Earnings Call, Aug 04, 2026

Communiqués

04/08	Exagen Inc. Reports Second Quarter 2026 Financial Results	GL
28/07	Exagen Inc. to Participate in Upcoming Investor Conference	GL
21/07	Exagen to Announce Second Quarter Financial Results on August 4, 2026	GL
21/07	Exagen to Announce Second Quarter Financial Results on August 4, 2026	AQ
01/06	Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus	GL
01/06	Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus	AQ
11/05	Exagen Inc. Reports First Quarter 2026 Results	GL
11/05	Exagen Inc. Reports First Quarter 2026 Results	AQ
27/04	Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026	GL
10/03	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results	GL
03/03	Exagen Inc. to Participate in Upcoming Investor Conferences	GL
03/03	Exagen Inc. to Participate in Upcoming Investor Conferences	AQ
24/02	Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026	GL
24/02	Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026	AQ
11/01	Exagen Inc. Announces Select Preliminary 2025 Financial Results	GL
11/11	Exagen Inc. to Participate in Fourth Quarter Investor Conferences	GL
04/11	Exagen Inc. Reports Strong Q3 2025 Results	GL
04/11	Exagen Inc. Reports Strong Q3 2025 Results	AQ
23/10/25	Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence	GL
21/10/25	Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025	GL
21/10/25	Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025	AQ
06/08/25	Exagen Inc. to Participate in Third Quarter Investor Conferences	GL
06/08/25	Exagen Inc. to Participate in Third Quarter Investor Conferences	AQ
29/07/25	Exagen Inc. Reports Strong Q2 2025 Results	GL
17/07/25	Exagen Inc. Appoints Chas McKhann to Board of Directors	GL